HomeAYTU • NASDAQ
add
Aytu Biopharma Inc
Previous close
$1.57
Day range
$1.55 - $1.66
Year range
$1.41 - $3.45
Market cap
10.22M USD
Avg Volume
37.87K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 16.57M | -6.98% |
Operating expense | 12.13M | -12.76% |
Net income | 1.47M | 118.15% |
Net profit margin | 8.89 | 119.51% |
Earnings per share | — | — |
EBITDA | 1.28M | 31.25% |
Effective tax rate | 27.04% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.11M | 0.72% |
Total assets | 115.83M | -12.84% |
Total liabilities | 86.00M | -14.61% |
Total equity | 29.83M | — |
Shares outstanding | 6.15M | — |
Price to book | 0.32 | — |
Return on assets | -0.31% | — |
Return on capital | -0.79% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 1.47M | 118.15% |
Cash from operations | -1.19M | -463.98% |
Cash from investing | 381.00K | 601.32% |
Cash from financing | 911.00K | 133.32% |
Net change in cash | 102.00K | 103.38% |
Free cash flow | -589.50K | 80.93% |
About
Founded
2002
Headquarters
Website
Employees
99
